Eledon Pharmaceuticals, Inc. Impairment of Long-Lived Assets Held-for-use
Eledon Pharmaceuticals, Inc. (ELDN) reported Impairment of Long-Lived Assets Held-for-use of $0 for the 12-month period ending 2024-12-31, per its 10-K/A filed 2025-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfLongLivedAssetsHeldForUse · last filed 2025-08-14
- Eledon Pharmaceuticals, Inc. impairment of long-lived assets held-for-use for the quarter ending 2014-12-31 was $0.00.
- Eledon Pharmaceuticals, Inc. impairment of long-lived assets held-for-use for fiscal 2024 was $0.00.
- Eledon Pharmaceuticals, Inc. impairment of long-lived assets held-for-use for fiscal 2023 was $0.00.
- Eledon Pharmaceuticals, Inc. impairment of long-lived assets held-for-use for fiscal 2022 was $0.00.
- Eledon Pharmaceuticals, Inc. impairment of long-lived assets held-for-use for fiscal 2021 was $0.00.
| Period end | Impairment of Long-Lived Assets Held-for-use 3 month | Impairment of Long-Lived Assets Held-for-use 9 month | Impairment of Long-Lived Assets Held-for-use 12 month |
|---|---|---|---|
| 2024-12-31 | $0.00 10-K/A · filed 2025-08-14 | ||
| 2023-12-31 | $0.00 10-K/A · filed 2025-08-14 | ||
| 2022-12-31 | $0.00 10-K/A · filed 2024-08-19 | ||
| 2021-12-31 | $0.00 10-K · filed 2023-03-30 | ||
| 2020-12-31 | $0.00 10-K · filed 2022-03-24 | ||
| 2019-12-31 | $0.00 10-K · filed 2021-03-31 | ||
| 2015-12-31 | $0.00 10-K · filed 2016-03-10 | ||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-26 | $0.00 10-K · filed 2015-03-26 | |
| 2014-09-30 | $0.00 10-Q · filed 2014-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |